Research conducted previously indicates that the levels of FCN3 expression were notably reduced in various cancerous tissues, including squamous cell lung carcinoma (32), hepatocellular carcinomas (33), and ovarian cancer (34). Here, FCN3 is linked to ovarian carcinoma.